Mark Crossley
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Mark Crossley
Earlier roles on record: CEO at Indivior Pharmaceuticals, Inc. (INDV) until May 8, 2025. The proxy statement of Indivior Pharmaceuticals, Inc. reports total compensation of $3,185,591 for Mark Crossley in fiscal 2025, including a base salary of $902,261. Mark Crossley has spoken on 1 earnings call across 1 company, most recently for Indivior Pharmaceuticals, Inc. on April 24, 2025.
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Start not stated–2025-05-08
Company network
Recorded roles and call appearances connecting this person to public companies.
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Indivior Pharmaceuticals, Inc. (INDV) | — | $902,261 | $3,185,591 |
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.